Tabnak Peyman, Ghasemi Yaser, Natami Mohammad, Khorram Roya, Ebrahimnezhad Mohammad
Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz 5165665931, Iran.
Faculty of Pharmacy, Ramsar Campus, Mazandaran University of Medical Sciences, Ramsar, Iran.
Biomed Pharmacother. 2023 Jan;157:114023. doi: 10.1016/j.biopha.2022.114023. Epub 2022 Nov 18.
N6-methyladenosine (mA) modification is the most abundant post-transcriptional regulation of RNAs in eukaryotes. Dysregulation of mA readers, writers, and erasers can significantly promote tumorigenesis by altering the expression of various genes. Wnt/β-catenin is an evolutionarily conserved signaling pathway that has recently been linked to the pathogenesis of many cancers. Given the significance of this pathway in regulating normal tissue homeostasis and stem cell differentiation, a subtle understanding of the molecular mechanism underlying its dysregulation is required for effective targeting. There is mounting evidence that mA regulators are highly implicated in the dysregulation of the Wnt/β-catenin signaling pathway. Since mA regulators can affect Wnt pathway components and dysregulation of either leads to carcinogenesis, this study aims to clarify the relationship between mA regulators and the Wnt/β-catenin signaling pathway to investigate their combined impact on tumorigenesis.
N6-甲基腺苷(m6A)修饰是真核生物中最丰富的RNA转录后调控方式。m6A阅读蛋白、写入蛋白和擦除蛋白的失调可通过改变各种基因的表达显著促进肿瘤发生。Wnt/β-连环蛋白是一条在进化上保守的信号通路,最近已被发现与许多癌症的发病机制有关。鉴于该通路在调节正常组织稳态和干细胞分化中的重要性,为了实现有效靶向,需要对其失调的分子机制有深入的了解。越来越多的证据表明,m6A调节剂与Wnt/β-连环蛋白信号通路的失调密切相关。由于m6A调节剂可影响Wnt通路成分,且二者任何一方的失调都会导致癌症发生,因此本研究旨在阐明m6A调节剂与Wnt/β-连环蛋白信号通路之间的关系,以研究它们对肿瘤发生的综合影响。
Biomed Pharmacother. 2023-1
J Hematol Oncol. 2024-6-18
Cancer Res. 2019-4-9
Biomed Pharmacother. 2020-12
Cell Commun Signal. 2022-9-9
Eur J Med Res. 2025-6-21
Naunyn Schmiedebergs Arch Pharmacol. 2025-5-20